Apogee Stock Jumps 87% in One Year as This Biotech Fund Lifts Stake to $93 Million
On February 13, 2026, Affinity Asset Advisors disclosed a purchase of 61,500 shares of Apogee Therapeutics (NASDAQ:APGE), an estimated $3.87 ...
Wednesday, April 1, 2026
Tag: Apogee
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.